» Articles » PMID: 36797032

Postoperative Lumbar Fusion Bone Morphogenic Protein-Related Epidural Cyst Formation

Overview
Specialty Neurology
Date 2023 Feb 16
PMID 36797032
Authors
Affiliations
Soon will be listed here.
Abstract

Bone morphogenetic protein is broadly used in spinal surgery to enhance fusion rates. Several complications have been associated with the use of bone morphogenetic protein, including postoperative radiculitis and pronounced bone resorption/osteolysis. Bone morphogenetic protein-related epidural cyst formation may represent another complication that has not been described aside from limited case reports. In this case series, we retrospectively reviewed imaging and clinical findings of 16 patients with epidural cysts on postoperative MR imaging following lumbar fusion. In 8 patients, mass effect on the thecal sac or lumbar nerve roots was noted. Of these, 6 patients developed new postoperative lumbosacral radiculopathy. During the study period, most patients were managed conservatively, and 1 patient required revision surgery with cyst resection. Concurrent imaging findings included reactive endplate edema and vertebral bone resorption/osteolysis. Epidural cysts had characteristic findings on MR imaging in this case series and may represent an important postoperative complication in patients following bone morphogenetic protein-augmented lumbar fusion.

Citing Articles

Novel Strategies for Spatiotemporal and Controlled BMP-2 Delivery in Bone Tissue Engineering.

Qi J, Wu H, Liu G Cell Transplant. 2024; 33:9636897241276733.

PMID: 39305020 PMC: 11418245. DOI: 10.1177/09636897241276733.


The Paracrine Effect of Hyaluronic Acid-Treated Endothelial Cells Promotes BMP-2-Mediated Osteogenesis.

Tong X, Chen J, Wang R, Hou D, Wu G, Liu C Bioengineering (Basel). 2023; 10(10).

PMID: 37892957 PMC: 10604672. DOI: 10.3390/bioengineering10101227.

References
1.
Choudhry O, Christiano L, Singh R, Golden B, Liu J . Bone morphogenetic protein-induced inflammatory cyst formation after lumbar fusion causing nerve root compression. J Neurosurg Spine. 2011; 16(3):296-301. DOI: 10.3171/2011.11.SPINE11629. View

2.
Haid Jr R, Branch Jr C, Alexander J, Kenneth Burkus J . Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J. 2004; 4(5):527-38. DOI: 10.1016/j.spinee.2004.03.025. View

3.
Shields L, Raque G, Glassman S, Campbell M, Vitaz T, Harpring J . Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine (Phila Pa 1976). 2006; 31(5):542-7. DOI: 10.1097/01.brs.0000201424.27509.72. View

4.
Carragee E, Hurwitz E, Weiner B . A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J. 2011; 11(6):471-91. DOI: 10.1016/j.spinee.2011.04.023. View

5.
Liu S, Wang Y, Liang Z, Zhou M, Chen C . Comparative Clinical Effectiveness and Safety of Bone Morphogenetic Protein Versus Autologous Iliac Crest Bone Graft in Lumbar Fusion: A Meta-analysis and Systematic Review. Spine (Phila Pa 1976). 2020; 45(12):E729-E741. PMC: 7282484. DOI: 10.1097/BRS.0000000000003372. View